CAPRICOR THERAPEUTICS, INC. — Investor Relations & Filings
Filings indexed
918
across all filing types
Latest filing
2026-04-10
Annual Report
Country
US
United States of America
Listing
US
CAPR
Capricor Therapeutics is a clinical-stage biotechnology company focused on the development of biologics, primarily cell and exosome-based technologies. The company's science is centered on its proprietary platform of allogeneic cardiosphere-derived cells (CDCs) and engineered exosomes to create novel therapeutics. Its lead candidate, Deramiocel (CAP-1002), is a cell therapy that has completed a pivotal Phase 3 study for the treatment of Duchenne muscular dystrophy (DMD). Capricor's pipeline leverages its core technologies to treat or prevent a broad range of serious diseases with significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - CAPRICOR THERAPEUTICS, INC. (0001133869) (Filer) | 2026-04-10 | English | |
| DEF 14A - CAPRICOR THERAPEUTICS, INC. (0001133869) (Filer) | 2026-04-10 | English | |
| 4 - CAPRICOR THERAPEUTICS, INC. (0001133869) (Issuer) | 2026-03-28 | English | |
| S-8 Filing | 2026-01-30 | English | |
| SCHEDULE 13G Filing | 2026-01-26 | English | |
| 4 Filing | 2026-01-07 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 34031593 | ARS - CAPRICOR THERAPEUTICS, INC. (0001133869) (Filer) | 2026-04-10 | English | ||
| 34027642 | DEF 14A - CAPRICOR THERAPEUTICS, INC. (0001133869) (Filer) | 2026-04-10 | English | ||
| 33067016 | 4 - CAPRICOR THERAPEUTICS, INC. (0001133869) (Issuer) | 2026-03-28 | English | ||
| 28106170 | S-8 Filing | 2026-01-30 | English | ||
| 28106060 | SCHEDULE 13G Filing | 2026-01-26 | English | ||
| 28106276 | 4 Filing | 2026-01-07 | English | ||
| 28106231 | 4 Filing | 2026-01-07 | English | ||
| 28106193 | 4 Filing | 2026-01-07 | English | ||
| 28106140 | 4 Filing | 2026-01-07 | English | ||
| 28106108 | 4 Filing | 2026-01-07 | English | ||
| 28106103 | 4 Filing | 2026-01-07 | English | ||
| 28106100 | 4 Filing | 2026-01-07 | English | ||
| 28106086 | 4 Filing | 2026-01-07 | English | ||
| 28106070 | 4 Filing | 2026-01-07 | English | ||
| 28106021 | 4 Filing | 2026-01-07 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CAPRICOR THERAPEUTICS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33192/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33192 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33192 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33192 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33192}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CAPRICOR THERAPEUTICS, INC. (id: 33192)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.